litlas
Log inCreate account

Mingqiang Li

Active 2008–2025

235
Papers
18,361
Citations
71
h-index
189
i10-index

Citations

Citations per year for Mingqiang Li1905: 1 citations1985: 1 citations2002: 1 citations2004: 1 citations2009: 6 citations2010: 9 citations2011: 16 citations2012: 13 citations2013: 20 citations2014: 63 citations2015: 126 citations2016: 122 citations2017: 181 citations2018: 367 citations2019: 687 citations2020: 730 citations2021: 892 citations2022: 927 citations2023: 964 citations2024: 1,456 citations2025: 937 citations2026: 27 citations1906–1984: no citations, so these years are not shown1986–2001: no citations, so these years are not shown2003: no citations, so this year is not shown2005–2008: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,920 citing papers, 41.4% of this breakdownUnited States: 1,237 citing papers, 13.1% of this breakdownIndia: 462 citing papers, 4.9% of this breakdownUnited Kingdom: 332 citing papers, 3.5% of this breakdownIran: 231 citing papers, 2.4% of this breakdownSouth Korea: 231 citing papers, 2.4% of this breakdownAustralia: 216 citing papers, 2.3% of this breakdownHong Kong: 169 citing papers, 1.8% of this breakdownItaly: 139 citing papers, 1.5% of this breakdownGermany: 138 citing papers, 1.5% of this breakdownSaudi Arabia: 133 citing papers, 1.4% of this breakdownSingapore: 131 citing papers, 1.4% of this breakdown
0%41.4%Other 22.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology26.5%
  • Computer Science20.9%
  • Medicine16.3%
  • Engineering12.5%
  • Materials Science11.8%
  • Immunology and Microbiology3.9%
  • Other8.1%

Topics

  • Advanced biosensing and bioanalysis techniques5.2%
  • RNA Interference and Gene Delivery5%
  • Nanoplatforms for cancer theranostics4.9%
  • Nanoparticle-Based Drug Delivery4.2%
  • Blockchain Technology Applications and Security4%
  • CRISPR and Genetic Engineering3%
  • Other73.7%

Coauthors

All papers

Open in search
  1. Healthcare Data Gateways: Found Healthcare Intelligence on Blockchain with Novel Privacy Risk Control

    Authors: Xiao Yue, Huiju Wang, Dawei Jin, Mingqiang Li, Wei Jiang - Journal of Medical Systems, J. Medical Syst. 2016 cited by 1,256

  2. Microneedle system for tissue engineering and regenerative medicine

    Authors: Yixin Zhang, Yanteng Xu, Huimin Kong, Jiabin Zhang, Hon Fai Chan, Jiasi Wang, Dan Shao, Yu Tao, Mingqiang Li - Exploration 2023 cited by 181

  3. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease

    Authors: Chengxin Shi, Jianati Dawulieti, Feiyu Shi, Chao Yang, Qian Qin, Tongfei Shi, Lizhao Wang, Hanze Hu, Madi Sun, Li Ren, Fangman Chen, Yawei Zhao, Feng Liu, Mingqiang Li, Lijun Mu, Dan Liu, Dan Shao, Kam W. Leong, Junjun She - Science Advances 2022 cited by 222

  4. DNA-based programmable gate arrays for general-purpose DNA computing

    Authors: Hui Lv, Nuli Xie, Mingqiang Li, Mingkai Dong, Chenyun Sun, Qian Zhang, L. Zhao, Jiang Li, Xiaolei Zuo, Haibo Chen, Fei Wang, Chunhai Fan - Nature 2023 cited by 197

  5. Spatiotemporal control of CRISPR/Cas9 gene editing

    Authors: Chenya Zhuo, Jiabin Zhang, Jung‐Hwan Lee, Ju Jiao, Du Cheng, Li Liu, Hae‐Won Kim, Yu Tao, Mingqiang Li - Signal Transduction and Targeted Therapy 2021 cited by 183

  6. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery

    Authors: Hongxia Wang, Mingqiang Li, Ciaran M. Lee, Syandan Chakraborty, Hae‐Won Kim, Gang Bao, Kam W. Leong - Chemical Reviews 2017 cited by 556

  7. Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation

    Authors: Huize Yan, Dan Shao, Yeh‐Hsing Lao, Mingqiang Li, Hanze Hu, Kam W. Leong - Advanced Science 2019 cited by 237

  8. Light: A Magical Tool for Controlled Drug Delivery

    Authors: Yu Tao, Hon Fai Chan, Bingyang Shi, Mingqiang Li, Kam W. Leong - Advanced Functional Materials 2020 cited by 304

  9. Alcohol consumption and risks of more than 200 diseases in Chinese men

    Authors: Pek Kei Im, Neil Wright, Ling Yang, Ka Hung Chan, Yiping Chen, Yu Guo, Huaidong Du, Xiaoming Yang, Daniel Avery, Shaojie Wang, Canqing Yu, Jun Lv, Robert Clarke, Junshi Chen, Rory Collins, Robin Walters, Richard Peto, Liming Li, Zhengming Chen, Iona Y. Millwood, China Kadoorie Biobank Collaborative Group, Chen Wang, Maxim Barnard, Derrick Bennett, Ruth Boxall, Johnathan Clarke, Ahmed Edris Mohamed, Hannah Fry, Simon Gilbert, Andri Iona, Maria Kakkoura, Christiana Kartsonaki, Hubert Lam, Kuang Lin, James H. Liu, Mohsen Mazidi, Sam Morris, Qunhua Nie, Alfred Pozarickij, Paul Ryder, Saredo Said, Dan Schmidt, Becky Stevens, Iain Turnbull, Baihan Wang, Lin Wang, Pang Yao, Xiao Han, Can Hou, Qingmei Xia, Chao Liu, Pei Pei, Dianjianyi Sun, Naying Chen, Duo Liu, Zhenzhu Tang, Ningyu Chen, Qilian Jiang, Jian Lan, Mingqiang Li, Yun Liu, Fanwen Meng, Jinhuai Meng, Rong Pan, Yulu Qin, Ping Wang, Sisi Wang, Liuping Wei, Liyuan Zhou, Caixia Dong, Pengfei Ge, Xiaolan Ren, Zhongxiao Li, Enke Mao, Tao Wang, Hui Zhang, Xi Zhang, Jinyan Chen, Ximin Hu, Xiaohuan Wang, Zhendong Guo, Huimei Li, Yilei Li, Min Weng, Shukuan Wu, Shichun Yan, Mingyuan Zou, Xue Zhou, Ziyan Guo, Quan Kang, Yanjie Li, Bo Yu, Qinai Xu, Liang Chang, Lei Fan, Shixian Feng, Ding Zhang, Gang Zhou, Yulian Gao, Tianyou He and 65 more - Nature Medicine 2023 cited by 179

  10. Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study

    Authors: Ka Hung Chan, Neil Wright, Dan Xiao, Yu Guo, Yiping Chen, Huaidong Du, Ling Yang, Iona Y. Millwood, Pei Pei, Junzheng Wang, Iain Turnbull, Simon Gilbert, Daniel Avery, Christiana Kartsonaki, Canqing Yu, Junshi Chen, Jun Lv, Robert Clarke, Rory Collins, Richard Peto, Liming Li, Chen Wang, Zhengming Chen, Daniel Avery, Derrick Bennett, Ruth Boxall, Sushila Burgess, Peter Ka Hung Chan, Yiping Chen, Zhengming Chen, Johnathan Clarke, Robert Clarke, Huaidong Du, Ahmed Edris Mohamed, Hannah Fry, Simon Gilbert, Mike Hill, Becky Im, Andri Iona, Maria Kakkoura, Christiana Kartsonaki, Hubert Lam, Kuang Lin, Mohsen Mazidi, Iona Y. Millwood, Sam Morris, Qunhua Nie, Alfred Pozarickij, Paul Ryder, Saredo Said, Dan Schmidt, Paul Sherliker, Rebecca Stevens, Iain Turnbull, Robin Walters, Lin Wang, Neil Wright, Ling Yang, Xiaoming Yang, Pang Yao, Yu Guo, Xiao Han, Can Hou, Qingmei Xia, Chao Liu, Jun Lv, Pei Pei, Canqing Yu, Junshi Chen, Zhengming Chen, Robert Clarke, Rory Collins, Yu Guo, Liming Li, Chen Wang, Jun Lv, Richard Peto, Robin Walters, Naying Chen, Duo Liu, Zhenzhu Tang, Ningyu Chen, Qilian Jiang, Jian Lan, Mingqiang Li, Yun Liu, Fanwen Meng, Jinhuai Meng, Rong Pan, Yulu Qin, Ping Wang, Sisi Wang, Liuping Wei, Liyuan Zhou, Caixia Dong, Pengfei Ge, Xiaolan Ren, Zhongxiao Li, Enke Mao, Tao Wang and 91 more - The Lancet Public Health 2022 cited by 178

  11. M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects

    Authors: Hong Xiao, Yu Guo, Bo Li, Mingqiang Li, Yong Wang, Shisong Han, Du Cheng, Xintao Shuai - ACS Central Science 2020 cited by 219

  12. Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers

    Authors: Jianati Dawulieti, Madi Sun, Yawei Zhao, Dan Shao, Huize Yan, Yeh‐Hsing Lao, Hanze Hu, Lianzhi Cui, Xiaoyan Lv, Feng Liu, Chun‐Wei Chi, Yue Zhang, Mingqiang Li, Ming Zhang, Huayu Tian, Xuesi Chen, Kam W. Leong, Li Chen - Science Advances 2020 cited by 182

  13. Engineered nanomedicines with enhanced tumor penetration

    Authors: Jianxun Ding, Jinjin Chen, Liqian Gao, Zhongyu Jiang, Yu Zhang, Mingqiang Li, Qicai Xiao, Su Seong Lee, Xuesi Chen - Nano Today 2019 cited by 424

  14. Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects

    Authors: Shaohui Deng, Mingqiang Li, Shuang Liu, Jifeng Chen, Mingqiang Li, Sing Yian Chew, Kam W. Leong, Du Cheng - Science Advances 2020 cited by 163

  15. Bioactive Injectable Hydrogel Dressings for Bacteria-Infected Diabetic Wound Healing: A “Pull–Push” Approach

    Authors: Kunbao Zhang, Chao Yang, Chuanxu Cheng, Chengxin Shi, Madi Sun, Hanze Hu, Tongfei Shi, Xuenian Chen, Xuan He, Xiao Zheng, Mingqiang Li, Dan Shao - ACS Applied Materials & Interfaces 2022 cited by 87

  16. Bioinspired Diselenide‐Bridged Mesoporous Silica Nanoparticles for Dual‐Responsive Protein Delivery

    Authors: Dan Shao, Mingqiang Li, Zheng Wang, Xiao Zheng, Yeh‐Hsing Lao, Zhimin Chang, Fan Zhang, Mengmeng Lu, Juan Yue, Hanze Hu, Huize Yan, Li Chen, Wen‐fei Dong, Kam W. Leong - Advanced Materials 2018 cited by 356

  17. Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy

    Authors: Ke Yi, Huimin Kong, Yeh‐Hsing Lao, Di Li, Rachel L. Mintz, Tianxu Fang, Guojun Chen, Yu Tao, Mingqiang Li, Jianxun Ding - Advanced Materials 2023 cited by 59

  18. Anti–phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy

    Authors: Chunxiong Zheng, Qingguo Zhong, Ke Yi, Huimin Kong, Fangfang Cao, Chenya Zhuo, Yanteng Xu, Run Shi, Enguo Ju, Wantong Song, Yu Tao, Xiaoyuan Chen, Mingqiang Li - Science Advances 2023 cited by 64

  19. A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines

    Authors: Hanze Hu, Chao Yang, Fan Zhang, Mingqiang Li, Zhaoxu Tu, Lizhong Mu, Jianati Dawulieti, Yeh‐Hsing Lao, Zixuan Xiao, Huize Yan, Wen Sun, Dan Shao, Kam W. Leong - Advanced Science 2021 cited by 84

  20. Nanotheranostics for the Management of Hepatic Ischemia‐Reperfusion Injury

    Authors: Yu Guan, Weifeng Yao, Ke Yi, Chunxiong Zheng, Shixian Lv, Yu Tao, Ziqing Hei, Mingqiang Li - Small 2021 cited by 114

  21. An Injectable Antibiotic Hydrogel that Scavenges Proinflammatory Factors for the Treatment of Severe Abdominal Trauma

    Authors: Chao Yang, Jianati Dawulieti, Kunbao Zhang, Chuanxu Cheng, Yawei Zhao, Hanze Hu, Mingqiang Li, Ming Zhang, Li Chen, Kam W. Leong, Dan Shao - Advanced Functional Materials 2022 cited by 90

  22. Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

    Authors: Fanghui Zhao, Ting Wu, Yuemei Hu, Lihui Wei, Mingqiang Li, Weijin Huang, Wen Chen, Shoujie Huang, Qinjing Pan, Xun Zhang, Ying Hong, Chao Zhao, Li Q, Kai Chu, Yunfei Jiang, Mingzhu Li, Jie Tang, Caihong Li, Dongping Guo, Li-Dong Ke, Xin Wu, Xingmei Yao, Jianhui Nie, Bizhen Lin, Yuqian Zhao, Meng Guo, Jun Zhao, Feng-Zhu Zheng, Xiaoqian Xu, Yingying Su, Qiu-Fen Zhang, Guang Sun, Fengcai Zhu, Shaowei Li, Yimin Li, Huirong Pan, Jun Zhang, You‐Lin Qiao, Ningshao Xia - The Lancet Infectious Diseases 2022 cited by 89

  23. Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma

    Authors: Huimin Kong, Enguo Ju, Ke Yi, Weiguo Xu, Yeh‐Hsing Lao, Du Cheng, Qi Zhang, Yu Tao, Mingqiang Li, Jianxun Ding - Advanced Science 2021 cited by 77

  24. Membrane‐Fusion‐Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy

    Authors: Chunxiong Zheng, Qingguo Zhong, Wantong Song, Ke Yi, Huimin Kong, Haixia Wang, Yu Tao, Mingqiang Li, Xuesi Chen - Advanced Materials 2022 cited by 59